GALMED PHARMACEUTICALS LTD. Payments to Acquire Debt Securities, Available-for-sale
GALMED PHARMACEUTICALS LTD. (GLMD) reported Payments to Acquire Debt Securities, Available-for-sale of $55.03 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2021-03-18
| Period end | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|
| 2020-12-31 | $55.03M 20-F · filed 2021-03-18 | |
| 2020-06-30 | $26.98M 6-K · filed 2020-08-06 | |
| 2019-12-31 | $72.60M 20-F · filed 2021-03-18 | |
| 2019-06-30 | $68.72M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $92.28M 20-F · filed 2021-03-18 | |
| 2017-12-31 | $3.87M 20-F · filed 2020-03-12 |